In situ preparation of magnetic nonviral gene vectors and magnetofection in vitro
- PMID: 20179330
- DOI: 10.1088/0957-4484/21/11/115103
In situ preparation of magnetic nonviral gene vectors and magnetofection in vitro
Abstract
Magnetic nonviral gene vectors were in situ prepared in the presence of ferrous salts and hyperbranched poly(ethylenimine)s (HPEI) with different molecular weights. HPEI, one of the most promising nonviral vectors, was not only utilized as the nanoreactor and stabilizer to prepare magnetic nanoparticles, but also skillfully used as a base supplier to avoid introducing alkali hydroxide or ammonia. Magnetic nonviral gene vectors with various magnetite contents and saturation magnetizations were obtained by changing the weight ratio of HPEI to FeSO(4).7H(2)O and the molecular weight of HPEI. MTT assays suggested that the resulting magnetite/HPEI gene vectors had lower cytotoxicity compared with pure HPEI. The magnetite/HPEI nonviral gene vectors were used for magnetofection. It was found that the luciferase expression level mediated by magnetite/HPEI in COS-7 cells under a magnetic gradient field was approximately 13-fold greater than that of standard HPEI transfection.
Similar articles
-
Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.Adv Drug Deliv Rev. 2011 Nov;63(14-15):1300-31. doi: 10.1016/j.addr.2011.08.002. Epub 2011 Aug 26. Adv Drug Deliv Rev. 2011. PMID: 21893135 Free PMC article. Review.
-
Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering.Artif Organs. 2008 Mar;32(3):195-204. doi: 10.1111/j.1525-1594.2007.00526.x. Epub 2008 Jan 14. Artif Organs. 2008. PMID: 18201284
-
Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors.Biomaterials. 2007 Jul;28(21):3245-54. doi: 10.1016/j.biomaterials.2007.03.033. Epub 2007 Apr 12. Biomaterials. 2007. PMID: 17466370
-
Dendrimer modified magnetic iron oxide nanoparticle/DNA/PEI ternary complexes: a novel strategy for magnetofection.J Control Release. 2011 Nov 30;152 Suppl 1:e159-60. doi: 10.1016/j.jconrel.2011.08.061. J Control Release. 2011. PMID: 22195820 No abstract available.
-
Nonviral Locally Injected Magnetic Vectors for In Vivo Gene Delivery: A Review of Studies on Magnetofection.Nanomaterials (Basel). 2021 Apr 22;11(5):1078. doi: 10.3390/nano11051078. Nanomaterials (Basel). 2021. PMID: 33922066 Free PMC article. Review.
Cited by
-
Challenges in development of nanoparticle-based therapeutics.AAPS J. 2012 Jun;14(2):282-95. doi: 10.1208/s12248-012-9339-4. Epub 2012 Mar 10. AAPS J. 2012. PMID: 22407288 Free PMC article. Review.
-
Application of magnetic nanoparticles to gene delivery.Int J Mol Sci. 2011;12(6):3705-22. doi: 10.3390/ijms12063705. Epub 2011 Jun 7. Int J Mol Sci. 2011. PMID: 21747701 Free PMC article. Review.
-
Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging.Int J Nanomedicine. 2014 Jul 10;9:3347-61. doi: 10.2147/IJN.S61463. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25045265 Free PMC article.
-
Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.Adv Drug Deliv Rev. 2011 Nov;63(14-15):1300-31. doi: 10.1016/j.addr.2011.08.002. Epub 2011 Aug 26. Adv Drug Deliv Rev. 2011. PMID: 21893135 Free PMC article. Review.
-
Systemic delivery and activation of the TRAIL gene in lungs, with magnetic nanoparticles of chitosan controlled by an external magnetic field.Int J Nanomedicine. 2016 Dec 2;11:6449-6458. doi: 10.2147/IJN.S118343. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27980403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources